Topic: Pandemic influenza.
Destination: The focus of this PAD Request for Proposals (RfP) is novel antivirals for pandemic influenza. Pandemic influenza remains is a substantial threat to public health. This RFP will support research designed to develop novel small-molecule antivirals targeting pandemic influenza. PAD funding can support preclinical activities and phase I clinical trials, but not later stage clinical trials. Special consideration will be given to therapeutic modalities that are suitable for deployment in low resource settings.
Duration: 1-3 years.
Llena el siguiente formulario para recibir más información: